Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Sex Transm Infect. 2016 Aug 12;93(2):137–143. doi: 10.1136/sextrans-2016-052629

Table 2.

Correlates of time-to-first incident Trichomonas vaginalis1

Characteristic T. vaginalis infections/Person-years Incidence (per 100 person-years) Univariate Analysis
Multivariate Analysis
HR (95% CI) p-value Adj HR (95% CI) p-value2
Overall 112/1078.9 10.4 (8.6–12.5)

Demographic

Age (years)
 ≤21 58/497.7 11.7 (9.0–15.1) 1.28 (0.89–1.86) 0.189
 >21 54/581.2 9.3 (7.1–12.1) ref
Level of education (years)
 ≤8 77/666.0 11.6 (9.2–14.5) 1.36 (0.91–2.01) 0.133
 >8 35/412.9 8.5 (6.1–11.8) ref
Current marital status
 Married 87/857.5 10.1 (8.2–12.5) 0.88 (0.56–1.38) 0.577
 Unmarried 25/221.3 11.3 (7.6–16.7) ref
Duration of partnership (years)3
 ≤1 30/270.1 11.1 (7.7–15.9) 1.14 (0.74–1.75) 0.544
 >1 67/686.2 9.8 (7.7–12.4) ref
Partner age3 (years older)
 ≥10 16/149.0 10.7 (6.6–17.5) 1.02 (0.59–1.75) 0.954
 <10 76/732.7 10.4 (8.3–13.0) ref
Employment status
 Employed 40/483.2 8.3 (6.1–11.3) 0.69 (0.47–1.02) 0.060 0.49 (0.310.79) 0.003
 Unemployed 72/595.7 12.1 (9.6–15.2) ref
Crowding living conditions (people/room)
 ≥3 41/335.7 12.2 (9.0–16.6) 1.26 (0.86–1.824) 0.243
 <3 71/742.0 9.6 (7.6–12.1) ref

Sexual behavior

Reported condomless sex (last month)
 Any 52/507.8 10.2 (7.8–13.4) 1.14 (0.77–1.68) 0.517
 None 60/565.4 10.6 (8.2–13.7) ref
Number of sexual partners (last month)
 >1 1/3.2 31.2 (4.4–221.4) 1.29 (0.52–22.98) 0.196
 ≤1 111/1075.3 10.3 (8.6–12.4) ref
Male partner circumcision status4
 Circumcised 18/316.4 5.7 (3.6–9.0) 0.48 (0.29–0.81) 0.006 0.42 (0.230.76) 0.004*
 Uncircumcised 80/657.6 12.2 (9.8–15.1) ref
Male partner HIV status4
 HIV-infected 1/13.7 7.3 (1.0–51.9) 0.82 (0.12–5.61) 0.840
 HIV-uninfected 65/718.6 9.0 (7.1–11.5) ref

Gynaecological history

Pregnancy status
 Pregnant 44/197.5 22.3 (16.6–29.9) 3.08 (1.93–4.91) <0.001 3.68 (1.907.15) <0.001*
 Postpartum 68/881.3 7.7 (6.1–9.8) ref
Number of living children
 ≥3 24/243.8 9.8 (6.6–14.7) 1.04 (0.64–1.70) 0.873
 <3 47/504.5 9.3 (7.0–12.4) ref
Time since previous birth (years)5
 <2 13/137.2 9.5 (5.5–16.3) 1.10 (0.60–2.03) 0.749
 ≥2 56/583.9 9.6 (7.4–12.4) ref
Reported vaginal washing (last week)
 Any 65/641.9 10.1 (7.9–12.9) 0.90 (0.62–1.31) 0.595
 None 47/435.3 10.8 (8.1–14.4) ref
Reported vaginal drying (last week)
 Any 15/106.5 14.0 (8.5–23.4) 1.22 (0.70–2.12) 0.482
 None 97/972.1 100 (8.2–12.2) ref
Self-reported history of STIs
 Any 9/68.7 13.1 (6.8–25.2) 1.30 (0.66–2.59) 0.448
 None 103/1010.2 10.2 (8.4–12.4) ref
Hormonal contraceptive use6
 Implant 3/50.8 5.9 (1.9–18.3) 0.86 (0.27–2.72) 0.795
 Injectable 5/74.9 6.7 (2.8–16.0) 0.84 (0.34–2.09) 0.713
 Oral 3/38.2 7.9 (2.5–24.4) 0.92 (0.28–2.97) 0.886
 None 57/717.4 7.9 (6.1–10.3) ref

STI diagnoses7

Non-TV curable STI 8
 Yes 13/63.3 20.5 (11.9–35.3) 2.03 (1.14–3.65) 0.017 2.10 (1.163.79) 0.014*
 No 78/778.0 10.0 (8.0–12.5) ref
Chlamydia trachomatis
 Yes 9/54.4 16.5 (8.6–31.8) 1.70 (0.87–3.30) 0.119
 No 103/1022.9 10.1 (8.3–12.2) ref
Neisseria gonorrhoeae
 Yes 7/23.0 30.4 (14.5–63.8) 2.90 (1.38–6.09) 0.005
 No 105/1054.3 9.96 (8.2–12.1) ref
Syphilis
 Yes 2/6.6 30.3 (7.6–121.0) 2.68 (0.64–11.3) 0.179
 No 89/834.8 10.6 (8.7–13.1) ref
Current bacterial vaginosis
 Yes 36/235.7 15.3 (11.0–21.2) 1.21 (0.82–1.79) 0.339
 No 75/572.0 13.1 (10.5–16.4) ref
Current candidiasis
 Yes 15/101.5 14.8 (8.9–24.5) 0.95 (0.55–1.64) 0.864
 No 97/711.3 13.6 (11.2–16.6) ref

HR = hazards ratio; Adj HR = adjusted hazards ratio; 95% CI = 95% confidence interval

1

Missing data not shown, all correlates assessed at enrolment unless indicated

2

Cox proportional hazards p-value adjusted for employment, male partner circumcision status, pregnancy status and other non-TV curable STIs detected at enrolment

3

Among women reporting current relationship

4

Male circumcision and HIV status of male partners reported by female partner

5

Among women with ≥1 children

6

Among postpartum women only

7

Chlamydia trachomatis, Neisseria gonorrhoeae and syphilis were assessed enrolment only. Bacterial vaginosis and candidiasis were assessed at enrolment and at follow up visits during pregnancy

8

Includes Chlamydia trachomatis, Neisseria gonorrhoeae and syphilis